Amoy Diagnostics is a provider of state-of-the-art molecular diagnostic products and services to healthcare providers, academic institutions and pharmaceutical companies. The company has a rich portfolio of tests that focuses on activating mutations in the EGFR pathway, chemotherapy response and infectious disease.

• The assays are based on a proprietary real-time PCR technology called “ADx-ARMS”.

• The assays have outstanding sensitivity (1%) and accuracy (99%).

• Three key tests – for mutations in the EGFR, KRAS and BRAF genes – have received both CE declarations for marketing in Europe and SFDA approval for clinical use in China.

• The assays are designed and tested in an ISO13485 certified laboratory and assembled in a dedicated GMP-compliant manufacturing plant.

• The assays are easy to perform, provide results in 90 minutes and have been validated on several PCR instruments that are commonly used in diagnostic laboratories.

http://www.amoydx.com/en/

Related products : Primerdesign, Argene, Sacacae, MRC Holland, Invivoscribe